A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Participants With Respiratory Insufficiency Expected to be Caused by Infection With Respiratory Viruses

Clinical trial NCT07633288 · RECRUITING

Trial details

NCT number: NCT07633288
Sponsor: SynAct Pharma Aps
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Viral Infection

Start date: 2026-05-01
Primary completion: 2027-08-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.